PMV Pharma IPO

PMV is a biotechnology company dedicated to selectively targeting mutant p53, providing unique therapies for any patient whose tumor harbors these gene mutations.

Total Funding to Date$170.8MM
Register for Details

For more details on financing and valuation for PMV Pharma, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

PMV Pharma Ticker Symbol


PMV Pharma Stock Price

$10.24 as of 11/25/22